A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children Academic Article Article uri icon

Overview

MeSH Major

  • Ependymoma
  • Sacrococcygeal Region
  • Teratoma

abstract

  • The trial was stopped after 41 patients were entered into the study; 18 patients received a placebo, and 23 received the urokinase. In the placebo group, six catheters were lost; in the urokinase group, eight were lost. The rate of bacterial clearance was equivalent for both. After administration of the study drug, each group had three episodes of fever and chills; two of these resulted in hypotension (one in each group). The authors conclude that slow-push urokinase infusion during established Hickman catheter sepsis does not result in improved catheter salvage or bacterial clearance. Slow intravenous push infusions in this setting may provoke hemodynamic instability even after initiation of antibiotics.

publication date

  • January 1994

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/0022-3468(94)90359-X

PubMed ID

  • 8078010

Additional Document Info

start page

  • 742

end page

  • 5

volume

  • 29

number

  • 6